News & Perspective

Mar 09, 2017

Mar 09, 2017

News Scan for Mar 09, 2017

MERS prevalence
Zika in African primates
E coli in soy nut butter
Plague vaccine
Faces of antibiotic resistance

Oct 16, 2007

Oct 16, 2007

US funds work on drugs for plague, tularemia, anthrax

(CIDRAP News) – The US government recently awarded contracts totaling about $34 million to two companies for development of drugs to treat pneumonic plague, tularemia, and anthrax, three of the diseases terrorists are deemed most likely to try to exploit.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»